Study of INCB123667 in Subjects With Advanced Solid Tumors
Incyte Corporation
Incyte Corporation
Pfizer
Turning Point Therapeutics, Inc.
Genentech, Inc.
Boston Scientific Corporation
Chinese University of Hong Kong
Sichuan Baili Pharmaceutical Co., Ltd.
Institute of Oncology Ljubljana
Ukrainian Society of Clinical Oncology
Sichuan Baili Pharmaceutical Co., Ltd.
RenJi Hospital
Shanghai Juncell Therapeutics
Sichuan Baili Pharmaceutical Co., Ltd.
Ruijin Hospital
Sichuan Baili Pharmaceutical Co., Ltd.
Changchun GeneScience Pharmaceutical Co., Ltd.
National Cancer Center Hospital East
Medstar Health Research Institute
The First Hospital of Jilin University
Institut du Cancer de Montpellier - Val d'Aurelle
Zhejiang Cancer Hospital
Huashan Hospital
University Hospital Heidelberg
Peking University Cancer Hospital & Institute
OncoSil Medical Limited
Taipei Veterans General Hospital, Taiwan
Orlando Health, Inc.
Renmin Hospital of Wuhan University
BioSyngen Pte Ltd
Peking University Cancer Hospital & Institute
Fujian Cancer Hospital
Sir Run Run Shaw Hospital
Sir Run Run Shaw Hospital
Sir Run Run Shaw Hospital
Fudan University
Sociedad Española de Medicina Nuclear e Imagen Molecular
Jiangxi Provincial Cancer Hospital